ConductScience.org, home

Gene · 4084

NIH grants1,780

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMXD1 papersNewest fiscal year
P50CA097186The Pacific Northwest Prostate Cancer SPORE22025
P50CA116201Mayo Clinic Breast Cancer SPORE22025
P50CA168504Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer22025
P50CA217694SPORE in Soft Tissue Sarcoma22025
R01ES005775Oncometabolites, DNA Repair, and Cancer22025
R35CA220500Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes22025
R35CA253180Targeting the MYC Pathway for the Treatment of Cancer22025
R35ES030429Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity22025
R35GM126983The systems biology of mitotic checkpoint signaling and its relevance to cancer cell biology22025
R35GM139539Investigating the Cell Division Machinery22025
R35GM147525Chromosome dynamics and organizations necessary for faithful chromosome segregation22025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies22025
T32MH079785Interdisciplinary And Translational Research Training In Neurohiv22025
U10CA180821Alliance for Clinical Trials in Oncology Operations Center - GY11 Funded Extension22025
U54AI170660Center for Structural Biology of HIV RNA22025
U54CA1567341/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research22025
ZIAAI000860Deciphering CTCF code in human host and viral epigenomes22025
ZIAHD008858Regulation of stem cell development during tissue remodeling22025
ZIAHD008869Modulation of TGF-beta signaling22025
F31GM154466Defining the role of DUSP12 in the regulation of cell division and apoptosis.12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4084/grants?page=3